Description
Discover how Novacomp boosted the operational capacity of a global clinical trial technology company by providing a specialized development team. Under a framework of high quality and technical precision, this team successfully helped nearly quadruple the volume of trials managed and expanded operations into new international markets, all while optimizing data integrity and ensuring patient safety in a highly regulated sector.
What will you discover in this document?
By reading this success story, you will learn about:
- The scalability challenge in Life Sciences: The client’s critical need to increase its capacity to develop personalized solutions and elevate the production volume of clinical trials without sacrificing service excellence or compromising patient safety.
- The technological solution and core systems: Large-scale development on the client’s proprietary platform, directly intervening across its three nerve systems: eConsent (a web-based control center), IRT (supply management and randomization), and eCOA (integrations and customized high-quality data reporting).
- Multi-tier development and best practices: The design and implementation of robust web applications using a stack composed of C#, SQL Server, and Angular, complemented by a low-code/no-code platform that standardized and added flexibility to trial configurations.
- The global impact results: How the organization successfully scaled from 25 clinical trials in 2021 to 95 in 2022, increased data point transfers by over 30% to reduce operational workload, and consolidated international expansion with the successful deployment of its first clinical trial in Tokyo.